Evidence map›Paper›PMID 42169107›Full record

ReviewJournal of neuroinflammation2026

The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation.

Katharina Gryksa, Maria Sibilia, Veit Rothhammer, Adrian Liston, Dietmar M Zaiss

Abstract readReview
In one paragraph

Review in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katharina GryksaDepartment of Immune Medicine, Faculty of Medicine, University of Regensburg, Regensburg, 93053, Germany. Katharina.Gryksa@ukr.de.
Maria SibiliaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
Veit RothhammerDepartment of Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, 91058, Germany.
Adrian ListonDepartment of Pathology, University of Cambridge, Cambridge, UK.
Dietmar M ZaissDepartment of Immune Medicine, Faculty of Medicine, University of Regensburg, Regensburg, 93053, Germany. Dietmar.Zaiss@ukr.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nervous and the immune system coevolved, and the crosstalk between both is critical for the maintenance of tissue homeostasis and mental health. In recent years, several examples have been revealed that the immune system influences behaviour, emotions, pain and even such fundamental needs as hunger. Reciprocally, several examples have become apparent in which neuronal innervation regulates local immune responses, wound healing and immune-mediated tissue homeostasis. Such findings demonstrate how well these two networks are interconnected with each other to sustain the body's well-being. Nonetheless, the underlying mechanisms that orchestrate this interconnection remain poorly understood. The Epidermal Growth Factor Receptor (EGFR) signalling pathway exemplifies this connection, being involved in both neuronal development and maintenance as well as in immune regulation and immune mediated wound healing. Particularly two antagonistic and leukocyte-derived EGF-like growth factors, Amphiregulin and HB-EGF, have gained appreciation for their role in the regulation of local immune responses and the maintenance of tissue homeostasis. In this review, we highlight the role of these two leukocyte-derived growth factors in the regulation of the nervous system and their importance in the bi-directional crosstalk between the immune and nervous systems during tissue homeostasis and inflammation. Ultimately, we propose that under inflammatory conditions, these two leukocyte-derived growth factors may substitute typical neurotrophic factors in their function.

Indexed as

ErbB ReceptorsImmune SystemNeuroimmunomodulationAnimalsHumansSignal TransductionErbB ReceptorsAREGEGFRHB-EGFImmune systemNervous systemNeuro-immune crosstalk

Identifiers

PMID42169107
PMCPMC13191983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.